Parcourir par sujet "dasabuvir plus ombitasvir plus paritaprevir plus ritonavir"
Voici les éléments 1-1 de 1
-
Prioritization for interferon-free regimens and potential drug interactions of current direct-acting anti-hepatitis C agents in routine clinical practice
(2017)Background We determined the proportions of patients with chronic hepatitis C (CHC) in association with possible prioritized indications for interferon-free regimens and the use of co-medications with potential drug-drug ...